Immetas and GC Biopharma partner for mRNA autoimmune treatments
Pharmaceutical Technology - 12-Oct-2023GC will design and deliver mRNA constructs; Immetas will identify therapeutic targets
Join the club for FREE to access the whole archive and other member benefits.
Healthcare reporter
Akosua Mireku is a healthcare reporter, with a focus on clinical research and pharmaceutical technology. She has been with the company since July 2022, contributing to the industry by covering important topics such as UK pharma collaborations and clinical trials. Akosua holds a degree from The University of Manchester, where she completed her studies in 2022. Actively engaged in the healthcare community, she frequently participates in industry events like the Outsourcing Clinical Trials conference. With over 300 connections, she is passionate about advancing knowledge in the clinical research sector.
Visit website: https://www.pharmaceutical-technology.com/author/akosuam/
See alsoDetails last updated 19-Oct-2024
GC will design and deliver mRNA constructs; Immetas will identify therapeutic targets